Document is current
Any future updates will be listed below
-
Authors
Aas, Christer F. https://orcid.org/0000-0002-6469-9354
Vold, Jørn Henrik
Skurtveit, Svetlana
Odsbu, Ingvild
Chalabianloo, Fatemeh
Lim, Aaron G.
Johansson, Kjell Arne
Fadnes, Lars Thore
-
Funding
Funding for this research was provided by:
Norges Forskningsråd (no. 269855)
Helse Vest (Åpen prosjektstøtte)
- License Information
-
More Information
Article History
Received: 26 March 2020
Accepted: 23 June 2020
First Online: 30 June 2020
Ethics approval and consent to participate
: The study was approved by the Regional Ethical Committee (no. 2018/939), Norway, on June 19, 2018 and by the Regional Ethical Review Committee in Stockholm (no 2018/2080–31/1), Sweden, on November 14, 2018. No informed consent from the participants was required.
: Not applicable.
: I.O. is employed at the Centre for Pharmacoepidemiology, Karolinska Institutet, which receives grants from several entities (pharmaceutical companies, regulatory authorities, and contract research organizations) for performance of drug safety and drug utilization studies, unrelated to this work. None of the other authors have competing interests.
